IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Sabby Management, LLC

Q3 2018 Holdings

Filed 2018-11-14 | 124 holdings | $13.3M | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↑Shares% Portfolio
Fibrogen IncCallCOM31572Q908$5.6K9160.0%
Unum Therapeutics IncCOM903214104$5.6K541,4200.0%
Viking Therapeutics IncPutCOM92686J956$6.7K3,8730.1%
Xeris Parmaceuticals IncCOM98422L107$8.6K486,9380.1%
Fibrogen IncPutCOM31572Q958$8.8K1,4440.1%
Odonate Therapeutics IncCOM676079106$10.2K523,6530.1%
Zosano Pharma CorpCOM98979H202$12.4K250,7830.1%
Zogenix IncCallCOM98978L904$13.1K2,6380.1%
Astrazeneca PLCPutADR046353958$14.3K3,6050.1%
Sarepta Therapeutics IncPutCOM803607950$14.7K9080.1%
Astrazeneca PLCCallADR046353908$15.2K3,8300.1%
Tilray IncPutCOM88688T950$15.3K1,0620.1%
Amarin Corporation PLCCallADR023111906$16.0K9,8340.1%
Nektar Therapeutics(NKTREUR)COM640268108$18.0K295,4050.1%
Spdr S&P BiotechCallTR78464A900$18.0K1,8790.1%
Sarepta Therapeutics IncCallCOM803607900$28.2K1,7460.2%
Nektar TherapeuticsPutCOM640268958$28.6K4,6850.2%
Esperion Therapeutics IncPutCOM29664W955$29.7K6,6920.2%
Ishares Russell 2000CallETF464287905$35.6K2,1150.3%
Biogen IncPutCOM09062X953$61.7K1,7470.5%
Ishares Russell 2000PutETF464287955$67.4K4,0000.5%
Spdr S&P 500CallTR78462F903$116.3K4,0010.9%
Spdr S&P 500PutTR78462F953$117.0K4,0260.9%
Biogen Inc(BIIB)COM09062X103$12.6M35,53494.2%
PreviousPage 3 of 3